Nasdaq
RLAY
Relay Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +0.3%
- 1 month
- +0.1%
- 1 year
- +459%
$19.75 · Mkt cap $3.78B
At the 6 Aug 2026 close
Nasdaq
Relay Therapeutics, Inc.
$19.75 · Mkt cap $3.78B
At the 6 Aug 2026 close
Relay Therapeutics, Inc. trades under the ticker RLAY on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $3.78B. The last closing price was $19.75, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +459%, and +0.1% over the past month. Returns are price returns and exclude dividends.
This page exists because RLAY is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.